Search results
Showing 1 to 5 of 5 results for vortioxetine
Evidence-based recommendations on vortioxetine (Brintellix) for treating major depressive episodes in adults.
In development [GID-TA11356] Expected publication date: 15 October 2025
Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]
In development [GID-TA11058] Expected publication date: TBC
Esketamine nasal spray for treatment-resistant depression (TA854)
Evidence-based recommendations on esketamine (Spravato) for treatment-resistant depression in adults.
This guideline covers identifying, treating and managing depression in people aged 18 and over. It recommends treatments for first episodes of depression and further-line treatments, and provides advice on preventing relapse, and managing chronic depression, psychotic depression and depression with a coexisting diagnosis of personality disorder.